Spiro George Rombotis - 21 Dec 2023 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role: President and CEO, Director
Signature: /s/ Spiro Rombotis
Issuer symbol: CYCC
Transactions as of: 21 Dec 2023
Net transactions value: +$20,122
Form type: 4
Filing time: 26 Dec 2023, 16:05:23 UTC
Previous filing: 03 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYCC	Common Stock	Purchase	$20,122	+6,070	+9.7%	$3.32	68,658	21 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYCC	Warrants (right to buy)	Purchase	$0	+6,070		$0.000000	6,070	21 Dec 2023	Common Stock	6,070	$3.19	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
F2	Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.